Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients

Annals of the Rheumatic Diseases

Volumn 71, Issue 10, 2012, Pages 1686-1691

  Lim, Lily Siok Hoon ^a   Benseler, Susanne M ^a   Tyrrell, Pascal N ^a   Harvey, Elizabeth ^a   Herbert, Diane ^a   Charron, Martin ^a   Silverman, Earl D ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CORTICOSTEROID; VITAMIN D;

ADOLESCENT; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EXPOSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; FAMILY HISTORY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; ILLNESS TRAJECTORY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; CHILD; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OSTEOPOROSIS;

EID: 84866086907     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200805     Document Type: Article

References (44)

1. Studnicka-Benke A, Steiner G, Petera P, et al. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067-74.
2. Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2000;2:33-7. (Pubitemid 32223681)
3. Gravallese EM, Goldring SR. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 2000;43:2143-51.
4. Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000;408:600-5.
5. Reid IR. Glucocorticoid effects on bone. J Clin Endocrinol Metab 1998;83:1860-2. (Pubitemid 28496306)
6. Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82. (Pubitemid 28335186)
7. Breslin LC, Magee PJ, Wallace JM, et al. An evaluation of vitamin D status in individuals with systemic lupus erythematosus. Proc Nutr Soc 2011;70:399-407.
8. Sochett EB, Mäkitie O. Osteoporosis in chronically ill children. Ann Med 2005;37:286-94. (Pubitemid 40911066)
9. Steelman J, Zeitler P. Osteoporosis in pediatrics. Pediatr Rev 2001;22:56-65. (Pubitemid 34075773)
10. Matkovic V, Jelic T, Wardlaw GM, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994;93:799-808.
11. Heaney RP, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporos Int 2000;11:985-1009. (Pubitemid 32144591)
12. Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 2007;56:1966-73. (Pubitemid 47110395)
13. Kalla AA, Fataar AB, Jessop SJ, et al. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34. (Pubitemid 23360013)
14. Lakshminarayanan S, Walsh S, Mohanraj M, et al. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8. (Pubitemid 32062031)
15. Lee C, Almagor O, Dunlop DD, et al. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 2006;45:53-60. (Pubitemid 43033875)
16. Lim SH, Benseler SM, Tyrrell PN, et al. Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients. Ann Rheum Dis 2011;70:1991-4.
17. Castro TC, Terreri MT, Szejnfeld VL, et al. Bone mineral density in juvenile systemic lupus erythematosus. Braz J Med Biol Res 2002;35:1159-63. (Pubitemid 36018691)
18. Kashef S, Saki F, Karamizadeh Z, et al. Bone mineral density in children with systemic lupus erythematosus and juvenile rheumatoid arthritis. Ann Saudi Med 2007;27:427-31. (Pubitemid 351234118)
19. Regio P, Bonf E, Takayama L, et al. The in uence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus 2008;17:787-92.
20. Lilleby V, Lien G, Frey Frøslie K, et al. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 2005;52:2051-9. (Pubitemid 40994329)
21. Bryk A, Raudenbush S. Hierarchical Models: Applications and Data Analysis Methods. Thousand Oaks: Sage 1992.
22. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classi cation of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
23. Stettler N. Body Mass Index and Z-Score Calculator. Philadelphia: The Children s Hospital of Philadelphia. http://stokes.chop.edu/web/zscore/index. php. (accessed 1 July 2010).
24. The American College of Rheumatology nomenclature and case de nitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
25. Weening JJ, D Agati VD, Schwartz MM, et al. The classi cation of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50.
26. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
27. Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identi cation of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
28. Bachrach LK, Sills IN. Clinical report - bone densitometry in children and adolescents. Pediatrics 2011;127:189-94.
29. Huber AM, Gaboury I, Cabral DA, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 2010;62:516-26.
30. Peel NF, Moore DJ, Barrington NA, et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
31. Raudenbush SW, Chan WS. Application of a hierarchical linear model to the study of adolescent deviance in an overlapping cohort design. J Consult Clin Psychol 1993;61:941-51. (Pubitemid 24006584)
32. Dubner SE, Shults J, Leonard MB, et al. Assessment of spine bone mineral density in juvenile idiopathic arthritis: impact of scan projection. J Clin Densitom 2008;11:302-8.
33. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393.
34. Slemenda CW, Reister TK, Hui SL, et al. Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity. J Pediatr 1994;125:201-7. (Pubitemid 24252998)
35. Saggese G, Baroncelli GI, Bertelloni S. Puberty and bone development. Best Pract Res Clin Endocrinol Metab 2002;16:53-64.
36. Alsufyani KA, Ortiz-Alvarez O, Cabral DA, et al. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol 2005;32:729-33. (Pubitemid 40524708)
37. Chen CJ, Yen JH, Tsai WC, et al. Decreased bone mineral density in premenopausal patients with systemic lupus erythematosus. Kaohsiung J Med Sci 1996; 12:567-72.
38. Formiga F, Moga I, Nolla JM, et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
39. Schapira D, Kabala A, Raz B, et al. Osteoporosis in murine systemic lupus erythematosus a laboratory model. Lupus 2001;10:431-8. (Pubitemid 32578619)
40. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 2000;19:1059-79. (Pubitemid 30238915)
41. Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Of cial Positions. J Clin Densitom 2008;11:29-42.
42. Gordon CM, Bachrach LK, Carpenter TO, et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008;11:43-58. (Pubitemid 351602187)
43. Nakhla M, Scuccimarri R, Duffy KN, et al. Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia. J Pediatr 2009;154:438-43.
44. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992;7:137-45.